Two High-Yield Dividend Stocks Worth Betting On

Well now, gather ’round and let me spin you a yarn about two peculiar critters in the stock market jungle-two high-yield dividend stocks that might just outlast your patience, if not your grandkids’ curiosity. Folks often think of dividends as those quiet streams trickling into their pockets every quarter, but sometimes they’re more like wild rivers ready to flood or dry up depending on how Mother Market feels that day.

But fear not, my fellow traders, for there are beasts in this financial forest sturdy enough to weather even the harshest storms. Let me introduce you to a couple of these hardy specimens-one an old monarch with a crown polished by time, and the other a scrappy pioneer eyeing a revolution round the bend.

1. AbbVie: The King Who Lost His Jewel But Found Two New Ones

AbbVie (ABBV), bless its heart, was born from the loins of Abbott Laboratories back in 2013-a separation akin to cutting off a limb and hoping it grows back stronger. And wouldn’t you know it? This little offspring inherited some mighty fine jewels, chief among them being Humira, which treated autoimmune diseases so well it became the golden goose of pharmaceuticals. Oh, and let’s not forget Androgel, because apparently men needed help keeping their testosterone levels up too.

Now here’s where the story gets interesting. You see, AbbVie didn’t stop at merely inheriting wealth; no sir, it kept right on building. Today, this company is what we call a “Dividend King,” wearing a crown earned through 53 years of consecutive dividend hikes. That’s longer than most marriages last these days! Since splitting from Abbott, AbbVie has grown its dividend by a whopping 310%. Its forward yield sits at a respectable 3.1%, though I reckon that number will look downright humble compared to what lies ahead.

And yet-and here’s the kicker-the loss of patent exclusivity for Humira could’ve spelled doom for any lesser king. But AbbVie? Why, they planned for this calamity like Noah prepping for the flood. They poured money into research and swallowed smaller companies whole, emerging with two promising heirs to Humira’s throne: Rinvoq and Skyrizi. These youngsters are already raking in over $25 billion combined, surpassing Humira’s peak earnings. If that ain’t something to write home about, I don’t know what is.

But wait, there’s more! AbbVie’s got a stable full of rising stars, including migraine fighters Qulipta and Ubrelvy, and cancer warriors Elahere and Epkinly. With nearly 90 programs in clinical testing, this company looks poised to keep its crown gleaming for decades to come. A trader’s dream, wouldn’t you say?

2. Verizon: The Telecom Titan Awaiting the 6G Thunderbolt

Next up is Verizon Communications (VZ), a telecom giant whose roots stretch back farther than most folks realize. Born in 2000 from the merger of Bell Atlantic and GTE, this company traces its lineage all the way to the breakup of AT&T in 1984. It’s been around long enough to witness the rise and fall of rotary phones, pagers, and flip phones alike.

For income investors, Verizon is a godsend. With a forward dividend yield of 5.9%, it practically throws cash at shareholders faster than a slot machine spits out quarters. And get this-it’s boosted its dividend for 18 straight years, showing no signs of slowing down. Sounds like a sure bet, doesn’t it?

Of course, competition in the telecom world is fiercer than a catfight over tuna, but Verizon holds its own admirably. In the second quarter of 2025, it boasted the highest revenue in the wireless industry. J.D. Power crowned it the best wireless network quality provider-for the 35th time, mind you-and RootMetrics declared its 5G network the fastest and most reliable in the U.S. Not bad for a relic of the analog age.

But the real treasure lies ahead. Whisperings of a telecom revolution have begun to ripple through the grapevine. By 2030, they say, super-high-speed 6G networks will arrive, promising holographic communications and untold wonders for the Internet of Things. When asked about it, Verizon’s consumer CEO Sowmyanarayan Sampath boldly proclaimed, “When 6G comes, we will be the first.” Lo and behold, the company’s already tinkering with a test 6G network in Dallas.

Imagine a world where smartphones are replaced by smart glasses or some contraption we can’t even fathom yet. No matter what gadget takes center stage, Verizon’s network will be the backbone holding it all together. For a trader, betting on such a future feels less like gambling and more like planting seeds in fertile soil. 🌱

2025-08-21 16:04

1. AbbVie: The King Who Lost His Jewel But Found Two New Ones

2. Verizon: The Telecom Titan Awaiting the 6G Thunderbolt

Read More